Abeona Therapeutics announced that it has joined the Rare Disease Company Coalition, an alliance of life science companies committed to discovering, developing, and delivering therapies for patients impacted by rare diseases. Abeona’s CEO Vish Seshadri, Ph.D., M.B.A., has been appointed to the RDCC’s Board of Directors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABEO:
- Abeona Therapeutics Joins Rare Disease Company Coalition
- Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Abeona Therapeutics prices 3.28M shares at $4.03 in registered direct offerig
- Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Abeona Therapeutics Announces Regulatory Update on Biologics License Application (BLA) for EB-101